Divis Laboratories Ltd (DIVISLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "6,014.50",
    "chg": -11.5,
    "chgp": "-0.19%",
    "dir": -1,
    "prev_price": "6,026.00",
    "mcapval": "162,004.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE361B01024",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "2.55 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3916489",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3916489.png",
        "date": "2026-03-25 15:00:34",
        "description": "Divis Laboratories Ltd, a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 15.11% surge in open interest in its derivatives segment, signalling increased market activity and shifting investor positioning. Despite this, the stock’s price performance remains subdued relative to its sector peers, reflecting a complex interplay of market sentiment and technical factors."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3916365",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3916365.png",
        "date": "2026-03-25 14:00:26",
        "description": "Divis Laboratories Ltd, a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 14.44% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning despite the stock underperforming its sector peers in recent sessions."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3916276",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3916276.png",
        "date": "2026-03-25 13:00:22",
        "description": "Divis Laboratories Ltd has witnessed a notable 12.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock’s recent price performance remains subdued relative to its sector, reflecting a complex interplay of bullish and bearish sentiments among traders."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-bearish-technicals-3910771",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3910771.png",
        "date": "2026-03-24 15:00:27",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 13.26% surge in open interest (OI) in its derivatives segment, signalling increased market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, raising questions about the directional bets underpinning this spike in OI."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-bearish-technicals-3910650",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3910650.png",
        "date": "2026-03-24 14:00:23",
        "description": "Divis Laboratories Ltd, a prominent large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.36% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning despite the stock’s underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "Divis Laboratories Sees Notable Surge in Derivatives Open Interest Amid Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-notable-surge-in-derivatives-open-interest-amid-bearish-momentum-3910114",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3910114.png",
        "date": "2026-03-24 11:00:05",
        "description": "Divis Laboratories Ltd, a large-cap heavyweight in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.08% surge in open interest (OI) in its derivatives segment, signalling a shift in market sentiment. Despite the stock trading below all major moving averages and a modest decline of 0.41% on the day, the spike in OI alongside rising volumes suggests increased investor participation and evolving directional bets."
      },
      {
        "title": "Divis Laboratories Ltd Surges 3.14% to Day's High of Rs 6158.95 — Outperforms Sector by 1.31 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-hits-intraday-high-with-30-surge-on-20-mar-2026-3903228",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_priceRelatedfactors_3903228.png",
        "date": "2026-03-20 13:15:51",
        "description": "The Sensex advanced 0.91% on 20 Mar 2026, yet Divis Laboratories Ltd outpaced the broader market with a 3.14% gain, reaching an intraday peak of Rs 6158.95. This 1.31-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a stock-specific strength rather than a general market uplift."
      },
      {
        "title": "Divis Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-is-rated-sell-3898448",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_mojoScore_3898448.png",
        "date": "2026-03-18 10:10:49",
        "description": "Divis Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 March 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      },
      {
        "title": "Divis Laboratories Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-faces-bearish-momentum-amid-technical-downgrade-3892657",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_technicaldot_3892657.png",
        "date": "2026-03-16 08:01:12",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from a Hold to a Sell rating reflects deteriorating technical conditions, underscored by weakening moving averages and bearish momentum oscillators."
      }
    ],
    "total": 600,
    "sid": "509760",
    "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "details": "Divi's Laboratories Limited has informed the Exchange regarding Disclosure of Related Party Transaction under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Divi's Laboratories Limited - Other General Purpose",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Divi's Laboratories Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Divi's Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Divi's Laboratories Limited has informed the Exchange regarding 'US-FDA Inspection of Unit -I at village Lingojigudem, Bhuvanagiri Yadadri District, Telangana'.",
      "source": "NSE",
      "caption": "Divi's Laboratories Limited - Updates",
      "datetime": "15-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-25 15:00:34

Divis Laboratories Ltd, a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 15.11% surge in open interest in its derivatives segment, signalling increased market activity and shifting investor positioning. Despite this, the stock’s price performance remains subdued relative to its sector peers, reflecting a complex interplay of market sentiment and technical factors.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-25 14:00:26

Divis Laboratories Ltd, a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 14.44% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning despite the stock underperforming its sector peers in recent sessions.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-25 13:00:22

Divis Laboratories Ltd has witnessed a notable 12.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock’s recent price performance remains subdued relative to its sector, reflecting a complex interplay of bullish and bearish sentiments among traders.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Bearish Technicals

2026-03-24 15:00:27

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 13.26% surge in open interest (OI) in its derivatives segment, signalling increased market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, raising questions about the directional bets underpinning this spike in OI.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Bearish Technicals

2026-03-24 14:00:23

Divis Laboratories Ltd, a prominent large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.36% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning despite the stock’s underperformance relative to its sector and benchmark indices.

Read full news article

Divis Laboratories Sees Notable Surge in Derivatives Open Interest Amid Bearish Momentum

2026-03-24 11:00:05

Divis Laboratories Ltd, a large-cap heavyweight in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.08% surge in open interest (OI) in its derivatives segment, signalling a shift in market sentiment. Despite the stock trading below all major moving averages and a modest decline of 0.41% on the day, the spike in OI alongside rising volumes suggests increased investor participation and evolving directional bets.

Read full news article

Divis Laboratories Ltd Surges 3.14% to Day's High of Rs 6158.95 — Outperforms Sector by 1.31 Percentage Points

2026-03-20 13:15:51

The Sensex advanced 0.91% on 20 Mar 2026, yet Divis Laboratories Ltd outpaced the broader market with a 3.14% gain, reaching an intraday peak of Rs 6158.95. This 1.31-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a stock-specific strength rather than a general market uplift.

Read full news article

Divis Laboratories Ltd is Rated Sell

2026-03-18 10:10:49

Divis Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 March 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Read full news article

Divis Laboratories Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-03-16 08:01:12

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from a Hold to a Sell rating reflects deteriorating technical conditions, underscored by weakening moving averages and bearish momentum oscillators.

Read full news article

View All News